An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype

American Journal of Pathology

Volumn 175, Issue 4, 2009, Pages 1555-1563

  Posey, Karen L ^a   Veerisetty, Alka C ^a   Liu, Pieman ^a   Wang, Huiqiu R ^a   Poindexter, Brian J ^a   Bick, Roger ^a   Alcorn, Joseph L ^a   Hecht, Jacqueline T ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Shriners Hospital for Children   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; MUTANT PROTEIN; SCLEROPROTEIN;

ACHONDROPLASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH PLATE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION;

EID: 73549096658     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090184     Document Type: Article

References (59)

1. DiCesare PE, Morgelin M, Mann K, Paulsson M: Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem 1994, 223:927-937
2. Hecht JT, Deere M, Putnam E, Cole W, Vertel B, Chen H, Lawler J: Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachondroplasia musculoskeletal tissues. Matrix Biol 1998, 17:269-278
3. Hedbom E, Antonsson P, Hjerpe A, Aeschlimann D, Paulsson M, Rosa-Pimentel E, Sommarin Y, Wendel M, Oldberg A, Heinegard D: Cartilage matrix proteins: an acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992, 267:6132-6136
4. Urban JP, Maroudas A, Bayliss MT, Dillon J: Swelling pressures of proteoglycans at the concentrations found in cartilaginous tissues. Biorheology 1979, 16:447-464
5. Kempson GE, Freeman MA, Swanson SA: Tensile properties of articular cartilage. Nature 1968, 220:1127-1128
6. Schmidt MB, Mow VC, Chun LE, Eyre DR: Effects of proteoglycan extraction on the tensile behavior of articular cartilage. J Orthop Res 1990, 8:353-363
7. Adams JC, Tucker RP, Lawler J: The thrombospondin gene family. Edited by JC Adams. Austin, TX, R.G. Landes Co., 1995, 191 p
8. Fang C, Carlson CS, Leslie MP, Tulli H, Stolerman E, Perris R, Ni L, Di Cesare PE: Molecular cloning, sequencing, and tissue and developmental expression of mouse cartilage oligomeric matrix protein (COMP). J Orthop Res 2000, 18:593-603
9. Fang C, Johnson D, Leslie MP, Carlson CS, Robbins M, Di Cesare PE: Tissue distribution and measurement of cartilage oligomeric matrix protein in patients with magnetic resonance imaging-detected bone bruises after acute anterior cruciate ligament tears. J Orthop Res 2001, 19:634-641
10. Posey KL, Davies S, Bales ES, Haynes R, Sandell LJ, Hecht JT: In vivo human Cartilage oligomeric matrix protein (COMP) promoter activity. Matrix Biol 2005, 24:539-549
11. Smith RK, Zunino L, Webbon PM, Heinegard D: The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 1997, 16:255-271
12. Fife RS, Brandt KD: Identification of a high-molecular-weight (greater than 400 000) protein in hyaline cartilage. Biochim Biophys Acta 1984, 802:506-514
13. DiCesare P, Hauser N, Lehman D, Pasumarti S, Paulsson M: Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett 1994, 354:237-240
14. Holden P, Meadows RS, Chapman KL, Grant ME, Kadler KE, Briggs MD: Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem 2001, 276: 6046-6055
15. Mann HH, Ozbek S, Engel J, Paulsson M, Wagener R: Interactions between the cartilage oligomeric matrix protein and matrilins: implications for matrix assembly and the pathogenesis of chondrodysplasias. J Biol Chem 2004, 279:25294-25298
16. Thur J, Rosenberg K, Nitsche DP, Pihlajamaa T, Ala-Kokko L, Heinegard D, Paulsson M, Maurer P: Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem 2001, 276:6083-6092
17. Rosenberg K, Olsson H, Morgelin M, Heinegard D: Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 1998, 273:20397-20403
18. Kipnes J, Carlberg AL, Loredo GA, Lawler J, Tuan RS, Hall DJ: Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage 2003, 11:442-454
19. Xu K, Zhang Y, Ilalov K, Carlson CS, Feng JQ, Di Cesare PE, Liu CJ: Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation. J Biol Chem 2007, 282:11347-11355
20. Chen FH, Thomas AO, Hecht JT, Goldring MB, Lawler J: Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 2005, 280:32655-32661
21. Briggs MD, Chapman KL: Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations. Hum Mutat 2002, 19:465-478
22. Briggs MD, Hoffman SM, King LM, Olsen AS, Mohrenweiser H, Leroy JG, Mortier GR, Rimoin DL, Lachman RS, Gaines ES: Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 1995, 10:330-336
23. Briggs MD, Mortier GR, Cole WG, King LM, Golik SS, Bonaventure J, Nuytinck L, De Paepe A, Leroy JG, Biesecker L, Lipson M, Wilcox WR, Lachman RS, Rimoin DL, Knowlton RG, Cohn DH: Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet 1998, 62:311-319
24. Chen H, Deere M, Hecht JT, Lawler J: Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes. J Biol Chem 2000, 275:26538-26544
25. Chen TL, Stevens JW, Cole WG, Hecht JT, Vertel BM: Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH. Matrix Biol 2004, 23:433-444
26. Cooper RR, Ponseti IV, Maynard JA: Pseudoachondroplastic dwarfism: a rough-surfaced endoplasmic reticulum storage disorder. J Bone Joint Surg Am 1973, 55:475-484
27. Delot E, Brodie SG, King LM, Wilcox WR, Cohn DH: Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture. J Biol Chem 1998, 273:26692-26697
28. DiCesare PE, Morgelin M, Carlson CS, Pasumarti S, Paulsson M: Cartilage oligomeric matrix protein: isolation and characterization from human articular cartilage. J Orthop Res 1995, 13:422-428
29. Dinser R, Zaucke F, Kreppel F, Hultenby K, Kochanek S, Paulsson M, Maurer P: Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways. J Clin Invest 2002, 110:505-513
30. Duke J, Montufar-Solis D, Underwood S, Lalani Z, Hecht JT: Apoptosis staining in cultured pseudoachondroplasia chondrocytes. Apoptosis 2003, 8:191-197
31. Ikegawa S, Ohashi H, Nishimura G, Kim KC, Sannohe A, Kimizuka M, Fukushima Y, Nagai T, Nakamura Y: Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia. Hum Genet 1998, 103: 633-638
32. Kleerekoper Q, Hecht JT, Putkey JA: Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain. J Biol Chem 2002, 277:10581-10589
33. Maddox BK, Mokashi A, Keene DR, Bachinger HP: A cartilage oligomeric matrix protein mutation associated with pseudoachondroplasia changes the structural and functional properties of the type 3 domain. J Biol Chem 2000, 275:11412-11417
34. McKeand J, Rotta J, Hecht JT: Natural history study of pseudoachondroplasia. Am J Med Genet 1996, 63:406-410
35. Merritt TM, Alcorn JL, Haynes R, Hecht JT: Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype. J Orthop Res 2006, 24:700-707
36. Merritt TM, Bick R, Poindexter BJ, Alcorn JL, Hecht JT: Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes. Am J Pathol 2007, 170:293-300
37. Unger S, Hecht JT: Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments. Am J Med Genet 2001, 106:244-250
38. Hecht JT, Hayes E, Haynes R, Cole WG: COMP mutations, chondrocyte function and cartilage matrix. Matrix Biol 2005, 23:525-533
39. Hecht JT, Hayes E, Snuggs M, Decker G, Montufar-Solis D, Doege K, Mwalle F, Poole R, Stevens J, Duke PJ: Calreticulin. PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes. Matrix Biol 2001, 20:251-262
40. Hecht JT, Montufar-Solis D, Decker G, Lawler J, Daniels K, Duke PJ: Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes. Matrix Biol 1998, 17:625-633
41. Hecht JT, Nelson LD, Crowder E, Wang Y, Elder FF, Harrison WR, Francomano CA, Prange CK, Lennon GG, Deere M, Lawler J: Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 1995, 10:325-329
42. Posey KL, Hayes E, Haynes R, Hecht JT: Role of TSP-5/COMP in pseudoachondroplasia. Int J Biochem Cell Biol 2004, 36:1005-1012
43. Hecht JT, Makitie O, Hayes E, Haynes R, Susic M, Montufar-Solis D, Duke PJ, Cole WG: Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate. J Orthop Res 2004, 22:759-767
44. Fiedler J, Stove J, Heber F, Brenner RE: Clinical phenotype and molecular diagnosis of multiple epiphyseal dysplasia with relative hip sparing during childhood (EDM2). Am J Med Genet 2002, 112:144-153
45. Chapman KL, Mortier GR, Chapman K, Loughlin J, Grant ME, Briggs MD: Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet 2001, 28:393-396
46. Jackson GC, Barker FS, Jakkula E, Czarny-Ratajczak M, Makitie O, Cole WG, Wright MJ, Smithson SF, Suri M, Rogala P, Mortier GR, Baldock C, Wallace A, Elles R, Ala-Kokko L, Briggs MD: Missense mutations in the beta strands of the single A-domain of matrilin-3 result in multiple epiphyseal dysplasia. J Med Genet 2004, 41:52-59
47. Mostert AK, Dijkstra PF, Jansen BR, van Horn JR, de Graaf B, Heutink P, Lindhout D: Familial multiple epiphyseal dysplasia due to a matrilin-3 mutation: further delineation of the phenotype including 40 years follow-up. Am J Med Genet A 2003, 120:490-497
48. Hou J, Putkey JA, Hecht JT: Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium binding. Cell Calcium 2000, 27:309-314
49. Posey KL, Yang Y, Veerisetty AC, Sharan SK, Hecht JT: Model systems for studying skeletal dysplasias caused by TSP-5/COMP mutations. Cell Mol Life Sci 2008, 65:687-699
50. Pirog-Garcia KA, Meadows RS, Knowles L, Heinegard D, Thornton DJ, Kadler KE, Boot-Handford RP, Briggs MD: Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP. Hum Mol Genet 2007, 16:2072-2088
51. Schmitz M, Niehoff A, Miosge N, Smyth N, Paulsson M, Zaucke F: Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations. Matrix Biol 2007, 27:67-85
52. Tsumaki N, Tanaka K, Arikawa-Hirasawa E, Nakase T, Kimura T, Thomas JT, Ochi T, Luyten FP, Yamada Y: Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol 1999, 144:161-173
53. Maroteaux P, Lamy M: Pseudo-achondroplastic forms of spondylo-epiphyseal dysplasias. Presse Med 1959, 67:383-386
54. Hashimoto Y, Tomiyama T, Yamano Y, Mori H: Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis. Am J Pathol 2003, 163:101-110
55. Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M: Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 2009, 417:651-666
56. Chen TL, Posey KL, Hecht JT, Vertel BM: COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes. J Cell Biochem 2008, 103:778-787
57. Schmitz M, Becker A, Schmitz A, Weirich C, Paulsson M, Zaucke F, Dinser R: Disruption of extracellular matrix structure may cause pseudoachondroplasia phenotypes in the absence of impaired cartilage oligomeric matrix protein secretion. J Biol Chem 2006, 281:32587-32595
58. Weirich C, Keene DR, Kirsch K, Heil M, Neumann E, Dinser R: Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP. Matrix Biol 2007, 26:314-323
59. Posey KL, Hankenson K, Veerisetty AC, Bornstein P, Lawler J, Hecht JT: Skeletal abnormalities in mice lacking extracellular matrix proteins: thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen. Am J Pathol 2008, 172:1664-1674